Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) NASDAQ: CPHR's share price crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$13.90 and traded as low as C$12.65. Cipher Pharmaceuticals shares last traded at C$12.65, with a volume of 18,572 shares traded.
Wall Street Analyst Weigh In
Separately, Stifel Nicolaus decreased their price objective on shares of Cipher Pharmaceuticals from C$19.00 to C$17.00 in a report on Monday, November 11th.
Read Our Latest Stock Analysis on Cipher Pharmaceuticals
Cipher Pharmaceuticals Price Performance
The company has a 50 day moving average of C$13.90 and a 200 day moving average of C$14.97. The company has a current ratio of 2.00, a quick ratio of 2.67 and a debt-to-equity ratio of 41.22. The firm has a market cap of C$227.11 million, a price-to-earnings ratio of 13.97 and a beta of 1.20.
Cipher Pharmaceuticals Company Profile
(
Get Free Report)
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cipher Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cipher Pharmaceuticals wasn't on the list.
While Cipher Pharmaceuticals currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
